Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
0
1
1
0
LUCIRA HEALTH INC
Share · US54948U1051 · LHDX (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of LUCIRA HEALTH INC
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 74,52 %
Shares Float 30,26 M
Shares Outstanding 40,6 M
Company Profile for LUCIRA HEALTH INC Share
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.
Company Data
Name LUCIRA HEALTH INC
Company Lucira Health, Inc.
Symbol LHDX
Website
https://www.lucirahealth.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US54948U1051
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Erik T. Engelson
Market Capitalization 18 Mio
Country United States of America
Currency USD
Employees 0,2 T
Address 1412 62nd Street, 94608 EmeryVille
IPO Date 2021-02-04
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | LHDX |
More Shares
Investors who hold LUCIRA HEALTH INC also have the following shares in their portfolio:
